Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 30.16
-1.84 (-5.75%)
Nov 21, 2025, 11:59 AM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 12.78 billion as of November 20, 2025. Its market cap has increased by 417.80% in one year.
Market Cap
12.78B
Enterprise Value
12.93B
Revenue
1.30B
Ranking
n/a
PE Ratio
87.69
Stock Price
30.16
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 12.78B, an increase of 23.92%. That is a compound annual growth rate of 6.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 12.78B | 276.47% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 323.98B |
| Hansoh Pharmaceutical Group Company | 236.23B |
| JD Health International | 214.50B |
| Innovent Biologics | 154.92B |
| WuXi Biologics | 130.87B |
| Sino Biopharmaceutical | 124.78B |
| Akeso | 103.08B |
| Sichuan Kelun-Biotech Biopharmaceutical | 101.34B |